Neos Therapeutics (NEOS) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NEOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 21, 2024 | finance.yahoo.comCara Therapeutics, Inc. (CARA)March 3, 2024 | afr.comAvenue Bank wins full APRA licence, bank guarantees in sightFebruary 9, 2024 | benzinga.comPresidio Partners 2007 GP, L.P.'s Net WorthDecember 14, 2023 | finance.yahoo.comUSAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic AccountsSeptember 11, 2023 | finanznachrichten.deEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsJuly 10, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Announces Submission of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval SupplementJuly 10, 2023 | finance.yahoo.comAytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval SupplementMay 29, 2023 | finance.yahoo.comADHD Therapeutics Market Size Worth USD 19740 Million by 2030 at 7.80% CAGR – Report by Market Research Future (MRFR)May 12, 2023 | marketwatch.comOverview of Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Dynamics and Trends for 2023-2030April 28, 2023 | marketwatch.comGlobal ADHD Medication Market Analysis and Business Growth Outlook [2023-2030]April 11, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market by Product Type and Consumers-2030April 4, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market 2023 Size and Forecast to 2031April 3, 2023 | benzinga.comAttention Deficit Hyperactivity Disorder Market to Register a Steady CAGR of 4.40% Between 2023 – 2031 | Growth Plus ReportsMarch 30, 2023 | marketwatch.comADHD Medication Market 2023 Size and Growth Forecast to 2028March 27, 2023 | marketwatch.com2023 Attention Deficit Hyperactivity Disorder (ADHD) Market: Top Players Best Practices and Sales Forecast 2030March 24, 2023 | marketwatch.comADHD Medication Market Outlook and Forecast till 2030March 21, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market Insights and Forecast to 2028March 16, 2023 | marketwatch.comThis report on ADHD Medication market presents a timeline of technical development and discusses how it affects the market.March 14, 2023 | marketwatch.comADHD Medication Market Analysis, Share by 2028February 27, 2023 | marketwatch.comGlobal Methylphenidate Drug Market Research Covers, Future Trends and Opportunities, Past, Present Data, and Deep Analysis 2030 By VMReportsFebruary 19, 2023 | marketwatch.comChildren Attention Deficit and Hyperactivity Disorder Market 2023: Strategies for Expanding into New Markets across Regions 2029February 15, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market Growth, Business Overview and Forecast to 2028January 23, 2023 | afr.comAvenue Bank aims to free up cash for small businessJanuary 20, 2023 | finance.yahoo.comNykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceJanuary 11, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market Size 2028 Size Estimation, New Investment Opportunities with Top Countries DataOctober 12, 2022 | marketwatch.comAttention Deficit and Hyperactivity Disorder Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028October 2, 2022 | marketwatch.comAttention Deficit Hyperactivity Market by Size Estimation, Share Analysis with Recent Developments, Business prospects and Forecast 2022-2031September 27, 2022 | ca.finance.yahoo.comAytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 RevenueSeptember 26, 2022 | benzinga.comAllarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of DirectorsAugust 19, 2022 | marketwatch.comADHD Treatment Market 2022: Industry Growth, Technology Features and Analysis By 2028 with Leading Regions and Countries DataJuly 16, 2022 | finance.yahoo.comCDB Aviation Executes Sale and Leaseback Transaction with New Middle Eastern Customer Jazeera AirwaysJuly 14, 2022 | nz.finance.yahoo.comAvidbots Neo Cleaning Robot Used by Many of the Newly Named Best Global AirportsJune 3, 2022 | marketwatch.comGlobal Attention Deficit Hyperactivity Disorder (ADHD) Market 2022: Share and Outlook of Regulatory Scenario by 2028May 25, 2022 | marketwatch.comAttention Deficit Hyperactivity Disorder Therapeutics Market 2022-2030 Global Industry Growth Opportunities, Analysis and Regional ForecastMay 24, 2022 | benzinga.comInsights on the Dental Partnering Global Market - Trends in Dental Dealmaking in the Biopharma Industry Since 2010April 27, 2022 | marketwatch.comStimulants Drugs Market Size 2022 by Research Methodology, Value Chain Analysis, Distributors and Forecast to 2029January 20, 2022 | finance.yahoo.comCobbs Creek Healthcare Hires Global Pharmaceutical Industry Leader Vince Mair as PresidentJanuary 18, 2022 | msn.comWho's Hiring In The Columbia Area? See New Local JobsDecember 13, 2021 | nasdaq.comAltimmune Appoints Richard Eisenstadt As Chief Financial Officer - Quick FactsDecember 13, 2021 | marketwatch.comAltimmune Names Richard Eisenstadt Finance ChiefDecember 9, 2021 | finance.yahoo.comGlobal Trauma Fixation Device Pipeline Products Market Landscape Report 2021 - ResearchAndMarkets.comNovember 15, 2021 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports First Quarter 2022 Financial ResultsSeptember 27, 2021 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial ResultsSeptember 17, 2021 | finance.yahoo.comImvax Appoints John M. Limongelli as Chief Legal Officer Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NEOS Media Mentions By Week NEOS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEOS News Sentiment▼0.000.55▲Average Medical News Sentiment NEOS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEOS Articles This Week▼00▲NEOS Articles Average Week Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CELU News Today RPHM News Today ANVS News Today IMMX News Today ELDN News Today CALC News Today BLRX News Today AEON News Today CKPT News Today KZR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEOS) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.